此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Potential Role of Acupuncture Treatment in Neuronal and Network Dysfunction in Patients With Vascular Cognitive Impairment

2019年10月1日 更新者:Chang Gung Memorial Hospital

Vascular cognitive impairment (VCI) is a broad dimensional term, ranging from mild cognitive impairment without incapacity on activity of daily living to vascular dementia (VaD), referred to as significant cognitive impairment and decline in function status.

In this three-year project, we aim to evaluate the effects of biochemical data, early clinical variables, neuroimaging results, and intervention of acupuncture treatment on vascular event related cognitive impairment in crossectional analysis and longitudinal follow-up.

研究概览

地位

未知

详细说明

Stroke is a common cerebrovascular disease of the central nervous system leading to serious medical complication. It results in a high mortality rate and increased disability rate. Stroke survivors may have long-lasting consequences, including motor dysfunction, sensibility dysfunction, and cognitive impairment]. Cognition is a key component of rehabilitation and recovery; therefore it is associated with poor engagement in rehabilitee and outcomes including increased mortality. As vascular dementia (VaD) is considered the second-most-common type of dementing illness, accounting for a significant proportion of total dementia case, vascular cognitive impairment (VCI) is a broader dimensional term, ranging from mild cognitive impairment without incapacity on activity of daily living to VaD, referred to as significant cognitive impairment and decline in function status.

Acupuncture is an ancient Chinese medical technique in which fine, stainless steel needles are inserted into certain anatomical locations of the body surface to elicit neurohormonal responses of the body system via nerve stimulation. Acupuncture are reported to be probably effective in improving cognitive function in vascular dementia animal models via multiple mechanisms such as anti-apoptosis, antioxidative stress reaction, and metabolism enhancing of glucose and oxygen.

Motor features may not parallel to the cognitive changes, it will serve as the disease progression marker. Unified Parkinson's Disease Rating Scale (UPDRS)-part III scores and NIH Stroke Scale (NIHSS) will be used.

  1. At Kaohsiung Chang Gung Memorial Hospital, all the patients (n=80) will be included and receive a Standardized Acupuncture intervention; 40 will be treated with regular medication; 40 will be treated with acupuncture and regular medication.
  2. For acupressure program, all participants are treated in supine position, and a certified TCM physician applied firm pressure (3 to 5 kg of pressure) with fingertips in a circular motion at a speed of 2 circles per second for a duration of one minute per acupoint. The complete process lasts for 8 minutes.

Cognitive function, Motor function, Mood and Sleep will be evaluated at baseline and follow-up period of time at 3 month, 6 month, and 12 month.

研究类型

介入性

注册 (预期的)

80

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Kaohsiung、台湾、83301
        • 招聘中
        • Kaohsiung Chang Gung Memorial Hospital
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

50年 至 80年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

1. Fulfill the diagnostic criteria of vascular cognitive impairment

Exclusion Criteria:

  1. Systemic inflammatory disease with on-going treatment
  2. Severe psychiatric disease, such as major depressive disorder or schizophrenia
  3. Severe traumatic brain injury
  4. Unable to tolerate exam of brain MRI

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
假比较器:regular medication treatment
acupuncture treatment on selected acupoint
实验性的:acupuncture and regular medication treatment
acupuncture treatment on selected acupoint

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change from baseline sleep quality at 3 months, 6 months, 12 months
大体时间:3 months, 6 months, 12 months
Analogous variables were extracted from actigraphy. The sleep variables collected were sleep start time, sleep end time, sleep duration, sleep efficiency, and wake after sleep onset time, and the activity variables collected were heart rate activity score,activity amount, and activity intensity
3 months, 6 months, 12 months

次要结果测量

结果测量
措施说明
大体时间
Change from baseline neuro-behavioral performances at 3 months, 6 months, 12 months
大体时间:3 months, 6 months, 12 months
Cognitive Abilities Screening Instrument (CASI). In addition to general cognitive performance, CASI was used to evaluate specific domains, including short-term memory, attention and concentration, abstraction, visual construction, language, and list-generating fluency.
3 months, 6 months, 12 months
Change from baseline motor function (UPDRS) at 3 months, 6 months, 12 months
大体时间:3 months, 6 months, 12 months
Unified Parkinson's Disease Rating Scale (UPDRS)-part III scores for parkinsonian features.
3 months, 6 months, 12 months
Change from baseline motor function (NIHSS) at 3 months, 6 months, 12 months
大体时间:3 months, 6 months, 12 months
NIH Stroke Scale (NIHSS) score 0-24.
3 months, 6 months, 12 months
Change from baseline continuous motor function at 3 months, 6 months, 12 months
大体时间:3 months, 6 months, 12 months
Physical activity was measured using accelerometers.
3 months, 6 months, 12 months
Change from baseline memory performances at 3 months, 6 months, 12 months
大体时间:3 months, 6 months, 12 months
Verbal memory were evaluated by using Chinese Version Verbal Learning Test (CVVLT).Visual-spatial abilities.
3 months, 6 months, 12 months
Change from baseline executive performances at 3 months, 6 months, 12 months
大体时间:3 months, 6 months, 12 months
Attention and executive function was evaluated by Trail Making Test B.
3 months, 6 months, 12 months
Change from baseline executive performances (Stroop interference test) at 3 months, 6 months, 12 months
大体时间:3 months, 6 months, 12 months
Attention and executive function was evaluated by Stroop interference test.
3 months, 6 months, 12 months
Change from baseline executive performances (calculation) at 3 months, 6 months, 12 months
大体时间:3 months, 6 months, 12 months
As the calculation ability depends on executive function, calculation ability was evaluated to reflect part of executive function.
3 months, 6 months, 12 months
Change from baseline abstract thinking at 3 months, 6 months, 12 months
大体时间:3 months, 6 months, 12 months
Abstract reasoning was evaluated by using similarities (conceptualization) in frontal assessment battery-Similarities.
3 months, 6 months, 12 months
Change from baseline language performances at 3 months, 6 months, 12 months
大体时间:3 months, 6 months, 12 months
Boston Naming Test were used to evaluate language ability in naming.
3 months, 6 months, 12 months
Change from baseline fluency performances at 3 months, 6 months, 12 months
大体时间:3 months, 6 months, 12 months
Semantic category fluency.
3 months, 6 months, 12 months
Change from baseline neuropsychiatric symptoms at 3 months, 6 months, 12 months
大体时间:3 months, 6 months, 12 months
The neuropsychiatric symptoms of the participants were measured using the Neuropsychiatric Inventory.
3 months, 6 months, 12 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:YaTing Chang, MD,PhD、Chang Gung Memorial Hospital

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2019年9月1日

初级完成 (预期的)

2020年9月1日

研究完成 (预期的)

2022年7月1日

研究注册日期

首次提交

2019年8月18日

首先提交符合 QC 标准的

2019年9月11日

首次发布 (实际的)

2019年9月12日

研究记录更新

最后更新发布 (实际的)

2019年10月3日

上次提交的符合 QC 标准的更新

2019年10月1日

最后验证

2019年8月1日

更多信息

与本研究相关的术语

其他研究编号

  • 201802103A3

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅